These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14088228)

  • 21. [Comparative indices of the formation and protective activity of antibodies during Honk Kong influenza A epidemics].
    Taros LIu; Rumel' NB; Smorodintsev AA
    Vopr Virusol; 1981; (1):59-64. PubMed ID: 6455011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparison of the hemagglutination-inhibition, neutralization and complement fixation tests in the assay of antibody to measles.
    CUTCHINS EC
    J Immunol; 1962 Jun; 88():788-95. PubMed ID: 13882798
    [No Abstract]   [Full Text] [Related]  

  • 24. ANTIGENIC VARIANTS OF INFLUENZA A2 VIRUS.
    PEREIRA HG; PEREIRA MS; LAW VG
    Bull World Health Organ; 1964; 31(1):129-32. PubMed ID: 14230885
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis of influenza virus type A and B infections].
    Ishida M
    Nihon Rinsho; 1990 Feb; 48 Suppl():260-4. PubMed ID: 2113124
    [No Abstract]   [Full Text] [Related]  

  • 26. [Various forms of respiratory viral diseases among children in Leningrad].
    Kaplan AS; Andreeva TV; Stupa VG
    Vopr Virusol; 1969; 14(5):607-11. PubMed ID: 4334576
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficiency of complement fixation (CF) test with internal nucleoprotein (NP) antigen and hemagglutination--inhibition (HI) test in the serodiagnosis of A and B influenza infections.
    Duca M; Moroşanu V; Handrache L; Ciubotaru V; Ionescu L; Liscă M
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):331-7. PubMed ID: 401012
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on complement fixation antigens of influenza virus. I. Type-specific and strainspecific complement fixation tests as compared with hemagglutination-inhibition test.
    CHANG SS; CHEN CY
    Taiwan Yi Xue Hui Za Zhi; 1961 Nov; 60():1010-25. PubMed ID: 13878105
    [No Abstract]   [Full Text] [Related]  

  • 29. [Formation of specific influenza antibodies in sheep].
    Glathe H
    Z Gesamte Hyg; 1967 Jul; 13(7):519-22. PubMed ID: 5594129
    [No Abstract]   [Full Text] [Related]  

  • 30. [A RAPID SEROLOGICAL REACTION FOR MEASURING ANTI-BOVINE PLAGUE ANTIBODIES].
    BOEGEL K; ENDERS-RUCKLE G; PROVOST A
    C R Hebd Seances Acad Sci; 1964 Jul; 259():482-4. PubMed ID: 14182546
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative evaluation of immunofluorescent (IgM and IgG) and complement-fixing antibodies in influenza A infection.
    Masihi KN; Köhler H; Lange W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):17-24. PubMed ID: 388933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of long-life radioisotopes Sr90 and Cs137 on the formation of antibodies to influenza A virus].
    Shubik VM
    Vopr Virusol; 1968; 13(5):592-5. PubMed ID: 5708929
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnostic significance of IgM class-specific antibodies in influenza].
    Ivanova LA; Ketiladze ES; Krylov VF; Poliakova TG; Grishchenko SV
    Vopr Virusol; 1986; 31(1):116-8. PubMed ID: 3515763
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of influenza A 2 antigens of various antibody sensitivity and of their ether preparations for the initiation of antibody cadastres].
    Gerth HJ; Stifter I
    Z Hyg Infektionskr; 1964; 150(2):121-35. PubMed ID: 5890644
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of two doses of influenza vaccine in stimulating antibody in volunteers.
    Howells CH; Evans AD; Vesselinova-Jenkins C
    Lancet; 1973 Jun; 1(7817):1436-8. PubMed ID: 4122998
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sero-epidemiological investigations of the effectiveness of influenza vaccine with attenuated live viruses of types A2 and B].
    Ivan A; Vancea G; Zvorişteanu V; Oană C; Rusu F; Gherman A; Meleghi M
    Stud Cercet Inframicrobiol; 1968; 19(5):355-61. PubMed ID: 5716054
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. II. Clinical reactions, hemagglutination-inhibitiong and strain and type-specific complement-fixing antibody responses in infants.
    Závadová H; Adam E; Vonka V; Domorázková E; Kratochvílová M; Burian V; Davenport FM
    Arch Gesamte Virusforsch; 1972; 36(1):53-61. PubMed ID: 5062439
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic effectiveness of amantadine hydrochloride in naturally occurring Hong Kong influenza--double-blind studies.
    Kitamoto O
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):1-7. PubMed ID: 4948478
    [No Abstract]   [Full Text] [Related]  

  • 39. Sero-epidemiological survey of influenza in Bucharest in the period from July 1967 to September 1968.
    Dobresco A; Scheau A; Bordeianu P; Cazacou E; Ivan IM; Busuioc C; Ionesco V; Stoicesco A
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):715-23. PubMed ID: 5400054
    [No Abstract]   [Full Text] [Related]  

  • 40. COFACTOR AND SPECIFIC ANTIBODIES AGAINST INFLUENZA VIRUSES. X. FORMATION OF 19S AND 7S TYPE INFLUENZA ANTIBODIES IN YOUNG AND ADULT RABBITS AND IN ROOSTERS; THE ROLE OF ANTIBODY COFACTOR.
    STYK B; HANA L
    Acta Virol; 1965 May; 9():200-9. PubMed ID: 14328218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.